ATE103496T1 - Impfstoff fuer den schutz von katzen gegen infektioese katzenperitonitis. - Google Patents

Impfstoff fuer den schutz von katzen gegen infektioese katzenperitonitis.

Info

Publication number
ATE103496T1
ATE103496T1 AT88309003T AT88309003T ATE103496T1 AT E103496 T1 ATE103496 T1 AT E103496T1 AT 88309003 T AT88309003 T AT 88309003T AT 88309003 T AT88309003 T AT 88309003T AT E103496 T1 ATE103496 T1 AT E103496T1
Authority
AT
Austria
Prior art keywords
vaccine
protection
against infectious
cats against
peritonitis
Prior art date
Application number
AT88309003T
Other languages
English (en)
Inventor
Jay Dean Gerber
Jerald Dee Ingersoll
Original Assignee
Norden Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norden Lab Inc filed Critical Norden Lab Inc
Application granted granted Critical
Publication of ATE103496T1 publication Critical patent/ATE103496T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT88309003T 1987-10-01 1988-09-29 Impfstoff fuer den schutz von katzen gegen infektioese katzenperitonitis. ATE103496T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10314487A 1987-10-01 1987-10-01
EP88309003A EP0310362B1 (de) 1987-10-01 1988-09-29 Impfstoff für den Schutz von Katzen gegen infektiöse Katzenperitonitis

Publications (1)

Publication Number Publication Date
ATE103496T1 true ATE103496T1 (de) 1994-04-15

Family

ID=22293621

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88309003T ATE103496T1 (de) 1987-10-01 1988-09-29 Impfstoff fuer den schutz von katzen gegen infektioese katzenperitonitis.

Country Status (16)

Country Link
EP (1) EP0310362B1 (de)
JP (1) JP2608935B2 (de)
KR (1) KR890006255A (de)
AT (1) ATE103496T1 (de)
AU (1) AU620819B2 (de)
CA (1) CA1337116C (de)
DE (1) DE3888775T2 (de)
DK (1) DK175715B1 (de)
ES (1) ES2063048T3 (de)
FI (1) FI94488C (de)
HU (1) HU205264B (de)
IL (1) IL87911A0 (de)
NO (1) NO177555C (de)
NZ (1) NZ226353A (de)
PT (1) PT88592B (de)
ZA (1) ZA887263B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667785A (en) * 1987-10-01 1997-09-16 Pfizer Inc. Vaccine for protection of cats against feline infectious peritonitis
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
EP0627936A4 (de) * 1992-02-18 1997-01-02 Parhelion Corp Impfstoff gegen die infektiöse peritonitis bei katzen und methode seiner herstellung.
US5670156A (en) * 1993-02-18 1997-09-23 Parhelion Corporation Feline infectious peritonitis vaccine and method of preparation
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
US6033845A (en) * 1996-12-18 2000-03-07 Engene Biotechnologies Inc Specific diagnostic for feline infectious peritonitis antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195130A (en) * 1978-04-20 1980-03-25 Cornell Research Foundation, Inc. Propagation of feline infectious peritonitis virus in tissue cultures
ATE1070T1 (de) * 1978-11-30 1982-06-15 The Wellcome Foundation Limited Abgeschwaechter stamm des bei feliden infektioese peritonitis verursachenden virus, verfahren zu seiner herstellung und ihn enthaltender impfstoff.
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
WO1987004624A1 (en) * 1986-02-06 1987-08-13 Schering Corporation Feline infectious peritonitis vaccine

Also Published As

Publication number Publication date
CA1337116C (en) 1995-09-26
AU2293188A (en) 1989-04-06
JPH01113321A (ja) 1989-05-02
PT88592A (pt) 1988-10-01
DE3888775T2 (de) 1994-07-14
EP0310362A3 (en) 1990-03-21
EP0310362A2 (de) 1989-04-05
NO177555C (no) 1995-10-11
NO884340L (no) 1989-04-03
FI884521A (fi) 1989-04-02
FI94488B (fi) 1995-06-15
DE3888775D1 (de) 1994-05-05
DK540688A (da) 1989-04-02
HUT47867A (en) 1989-04-28
EP0310362B1 (de) 1994-03-30
JP2608935B2 (ja) 1997-05-14
NZ226353A (en) 1991-07-26
FI94488C (fi) 1995-09-25
FI884521A0 (fi) 1988-09-30
KR890006255A (ko) 1989-06-12
IL87911A0 (en) 1989-03-31
ES2063048T3 (es) 1995-01-01
NO884340D0 (no) 1988-09-30
ZA887263B (en) 1989-09-27
AU620819B2 (en) 1992-02-27
PT88592B (pt) 1993-03-31
DK175715B1 (da) 2005-01-31
NO177555B (no) 1995-07-03
HU205264B (en) 1992-04-28
DK540688D0 (da) 1988-09-28

Similar Documents

Publication Publication Date Title
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
GR3017770T3 (en) Feline infectious peritonitis virus diagnostic tools.
BR9107294A (pt) Derivados do GP160 e vacinas baseadas no GP160 ou um derivado do mesmo, contendo um adjuvante
DK437980A (da) Felin infektioest peritonitis-virum og vacciner fremstillet deraf
ZA964679B (en) Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
DE69634820D1 (de) Impfstoff gegen mehrere fiv-subtypen
ATE103496T1 (de) Impfstoff fuer den schutz von katzen gegen infektioese katzenperitonitis.
DK1087014T3 (da) Svinepestvirusvaccine og -diagnostik
MX9102757A (es) Vacuna de virus de enfermedad de marek sin celulas.
DE69210346T2 (de) Atmungskrankheitimpfstoff für Katzen
DE68927340D1 (de) Biologischer impfstoff, wirksam gegen aphanomyces
ATE144103T1 (de) Biologischer impfstoff, wirksam gegen aphanomyces
NL300254I2 (nl) Verzwakte herpesvirussen, herpesvirussen die vreemd DNA omvatten dat codeert voor een aminozuursequentie en vaccin dat het bevat
ATE86500T1 (de) Abgeschwaechtes virus und impfstoffe davon zur verwendung gegen infektionen bei gefluegel, verursacht durch truthahn-rhinotracheitis-virus.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time